Syngene International announces executive leadership transition in CDMO division

Syngene International Limited, a leading contract research and manufacturing organization, has announced a change in its senior management personnel. Mr. Alex Del Priore, head of large molecules CDMO and a member of the executive committee, will be leaving the company by mutual consent to pursue other career opportunities, with immediate effect from November 18, 2025.

Concurrently, Dr. Rohtash Kumar has been appointed as the new head of CDMO, small and large molecule, and a member of the executive committee, effective from December 1, 2025. Dr. Kumar brings over two decades of experience in R&D, manufacturing, and executive leadership across global CDMO organizations, most recently leading global technology and development at Veranova. He holds a Ph.D. in Organic Chemistry from the University of Delhi, an M.Sc. in Organic Chemistry, and an MBA from Chaudhary Charan Singh University.

These changes reflect a strategic realignment within the company's organizational structure, specifically impacting its contract development and manufacturing operations. The announcement was made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.